home > research channels > sectors > pharma


Latest News
04-Oct-2018 US May Dilute Norm Used to Delay Generics
19-Sep-2018 Spanish Partner Gets Nod for Drug in Europe: Sun
18-Sep-2018 SC Lifts Ban on Saridon, 2 Other Combo Drugs
12-Sep-2018 E-pharma Draft Triggers Over-regulation Worries
11-Sep-2018 Pharma Authority Faces Heat for Slow Reforms
  more...
Latest Reports
Oct-18 US generics – on a marginal recovery path - Motilal Oswal  
Oct-18 2QFY19 Results Preview - HDFC Securities  
Oct-18 Analysis of related party transactions - Edelweiss Securities  
Oct-18 DTAB report puts more risk on the 900+ non-reviewed FDCs - Emkay Research  
Oct-18 Muted Performance on the Cards - Reliance Securities Ltd.  
  more...

Quarterly Summary (March Quarter)
Desc Current Previous Per.Chg
Sales 6353.8 5167.9 22.9
Otherincome 252.5 154.9 63.0
Expense 5079.5 4329.2 17.3
RawMaterial 2113.8 1745.1 21.1
StaffCost 966.6 826.5 17.0
ExciseDuty 0.0 74.3 -100.0
OtherExp 1375.4 1238.2 11.1
Interest 134.0 126.2 6.2
GrossProfit 1454.0 953.0 52.6
Depreciation 256.6 245.0 4.7
Tax 409.0 50.1 716.3
NetProfit 843.9 652.4 29.4
Total.Comp 24 -- --
Source: ETIG Database

Sectoral Companies As on 19 Oct 2018
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 145973.41
Cipla 51040.77
Aurobindo Ph 43801.88
Dr.Reddy's 42284.58
Lupin 39685.07
Biocon 39507.00
Cadila Healt 38081.64
Piramal Entp 34350.91
Divi's Lab 34209.87
Torrent Phar 26455.01
GlaxoSmith.P 24117.21
Alkem Labora 23187.32
Glenmark Pha 16917.89
  click here for the complete list